Bing

SEARCH HISTORY

Pfizer (NYSE:PFE) recently announced its decision to acquire two meningitis vaccines, Nimenrix and Mencevax, from GlaxoSmithKline (GSK) for $130 million. [1] Both vaccines are approved for commercial sales and the move builds upon Pfizer’s last …
Trefis · 1 day ago
vaccines
The Company is now working with 18 of the top 20 global pharmaceutical companies including Merck, Pfizer and Novartis. GSK licensed from Codexis the CodeEvolver® directed evolution technology platform, which …
nanalyze.com · 6/26/2015
GlaxoSmithKline said on Monday that it is selling its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals - a subsidiary of Pfizer Inc - for €115m. The sale follows commitments given to the European Commission and other …
Hargreaves Lansdown · 6/22/2015
More from Bing News
the firm informed the Bombay Stock Exchange. Current MD Joshipura will vacate office effective August 1. Vaidheesh was Johnson & Johnson's vice president, corporate government affairs, Asia Pacific. Though GSK did not reveal Joshipura's next move ...
Economic Times · 6/23/2015
For listed subsidiaries of consumer multinational companies in India, a key driver of medium-term operational performance and stock returns has been the alignment ... which is possibly struggling to make expected …
Financial Express · 6/29/2015
India
... announcement http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q4-2012... UV Flu Technologies (OTC BB: UVFT) stock is up over 45% in the last week, and is still severely undervalued at these levels! UVFT's...
Stockhouse · 6/23/2015
Shares of GLAXOSMITHKLINE PHARMACEUTICALS LTD. was last trading in BSE at Rs.3280.85 as compared to the previous close of Rs. 3296.35. The total number of shares traded during the day was 629 in over 182 trades. The stock hit an intraday …
Equity Bulls · 6/22/2015
GlaxoSmithKline Pharmaceutic…
GlaxoSmithKline plc (NYSE: GSK) has been named to the Dividend Channel ”International S.A.F.E. 10” list, signifying an international stock with above-average ”DividendRank” statistics including a strong 5.5% yield, as well as a superb track record ...
Forbes · 6/9/2015
The current sell-off in global stock markets is a timely reminder to investors of ... As these drugs come out of patent cheaper copies are eroding the market. AstraZeneca and GlaxoSmithKline are fighting back and have …
Daily Telegraph · 6/29/2015
Wagner and the other participants accused Stiefel of encouraging them to sell their shares in the company's employer stock plan at around $15,000 per share while hiding merger negotiations with GlaxoSmithKline LLC that ultimately resulted in payouts of $ ...
Bloomberg BNA · 6/23/2015

GlaxoSmithKline

Company
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world'…
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world's sixth-largest pharmaceutical company in 2014, after Pfizer, Novartis, Sanofi, Hoffmann-La Roche and Merck. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.
Data from: Wikipedia